Study Shows WATS3D Biopsy Increases Detection of Pre-Cancer in the Esophagus by 50% in Post-Ablation Patients

CDx Diagnostics announced today that a new study adds to the growing body of evidence supporting the use of Wide Area Transepithelial Sampling with 3-Dimensional analysis (WATS^3D) as a surveillance tool in patients who have received ablation therapy for Barrett’s esophagus.
http://www.digitaljournal.com/pr/1523611